Company Overview and News

34
Piedmont Lithium: Should You Buy This Nasdaq-Listed U.S. Explorer?

2018-06-06 seekingalpha
Piedmont benefits from its location in North Carolina, and, potentially, from synergies with Albemarle and FMC.
RRSSF PDDTF ALB ASX RDRUY AZZVF AVZ

0
AVZ returns strong results from Manono lithium proejct

2018-06-03 australianmining.com.au
Assay results from AVZ Minerals’ Manono lithium project in the Democratic Republic of Congo (DRC) have returned result as high as 1.52 per cent lithium oxide at 284.47m. About 50 per cent of planned drilling at the 20,000m project has now been completed.
AVZ

45
0
AVZ Minerals bullish on expectations for DRC lithium project

2018-04-26 proactiveinvestors.com.au
AVZ Minerals Ltd. (ASX:AVZ) managing director Nigel Ferguson speaks to Proactive Investors about the company’s progress with and high expectations for the lithium-rich LCT (lithium, caesium, tantalum) Manono Project in the Democratic Republic of Congo (DRC).
AVZ

0
AVZ Minerals in trading halt responding to ASX query, lithium drilling continues

2018-04-12 proactiveinvestors.com.au
AVZ Minerals Ltd (ASX:AVZ) entered a trading halt yesterday pending the release of a response to an ASX query.
AVZ

0
Black Mountain Resources a leading ASX gainer on DRC lithium farm-ins

2018-04-05 proactiveinvestors.com.au
Black Mountain Resources Ltd (ASX:BMZ) is a leading ASX gainer on news of entering agreements to farm into lithium prospects in the Democratic Republic of Congo and the raising of $500,000 by way of convertible note.
BMZ AVZ

48
Lithium Junior Miner News For The Month Of March 2018

2018-03-28 seekingalpha
Lithium spot and contract price news - Lithium spot prices moved sideways, whilst 2018 global LCE contract prices are up about 20%.
LIT SAV LAXXF LIACF PFFOF WML POR ABEPF SQM MLNLF VLKAY AVLNF AIS.H KDR SYA STLHF WMLLF LNRDY HMGLF PEMIF ABE NGZ LMMFF GXY LRS PLU MNIKF HNR AMLM AVL ALB DMNXF NMKEF LKE MGXMF PLUUF DJIFF NMX PSC EMH CRECF ERPNF PLS MSB DJI SSDIY PDDTF NTTHF AVLIF ORE AVZ AJM

15
Hot Copper Popularity Is Important For Lithium Junior Companies

2018-03-22 seekingalpha
Remember those popular kids in high school? Yeah, the ones you hated? You should invest in them.
PLS PILBF SYA LTHHF DMNXF MS.PRE MS.PRF MS.PRG MS.PRA GALXF GXY MS.PRI ALTAF MS.PRK AZZVF MS AVZ AJM

47
Tyranna Resources to acquire high-grade cobalt and base metals project, shares jump 30%

2018-03-22 proactiveinvestors.com.au
Tyranna Resources Ltd (ASX:TYX) has entered into a binding option agreement to acquire 100% of the Goodsprings Cobalt and Base Metals Project in the US state of Nevada.
RGORF TSLA GOLD TYX RRS AVZ GOLD

0
AVZ signs MOU with Chinese battery firm

2018-03-12 businessnews.com.au
Lithium explorer AVZ Minerals has signed a memorandum of understanding with a major Chinese battery producer for potential investment and offtake opportunities.
AVZ

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...